A collection of reagents and other associated materials intended to be used for the qualitative and/or (semi-)quantitative detection of cannabinoids and/or cannabinoid metabolites (i.e., natural, synthetic) in a clinical specimen within a short period, relativ
| Company | Devices | Share |
|---|---|---|
| Safecare Biotech (Hangzhou) Co., Ltd. | 22 | 16% |
| Easy Healthcare Corporation | 18 | 13% |
| Germaine Laboratories, Inc | 11 | 8% |
| Hangzhou Alltest Biotech Co., Ltd. | 10 | 7% |
| Mercedes Medical, Llc | 10 | 7% |
| Medical Distribution Group Inc | 8 | 6% |
| Co-Innovation Biotech Co., Ltd | 6 | 4% |
| Alfa Scientific Designs, Inc. | 6 | 4% |
| Guangzhou Decheng Biotechnology Co., Ltd | 5 | 4% |
| Shenzhen Bioeasy Biotechnology Co., Ltd | 4 | 3% |
| Assure Tech. (Hangzhou) Co., Ltd. | 4 | 3% |
| Ucp Biosciences, Inc. | 4 | 3% |
Company = labeler of record on GUDID. 35 companies in total; top 12 shown. Click headers to sort.
Sample of brand names as labelled; no endorsement. Ask us for the full list with company, model and UDI.
| Code | Name | Devices |
|---|---|---|
| LDJ | Enzyme Immunoassay, Cannabinoids | 102 |
| NFW | Test, Cannabinoid, Over The Counter | 39 |
| DIO | Enzyme Immunoassay, Cocaine And Cocaine Metabolites | 37 |
| DKZ | Enzyme Immunoassay, Amphetamine | 30 |
| DJG | Enzyme Immunoassay, Opiates | 26 |
| DNK | Thin Layer Chromatography, Morphine | 25 |
Use these as the dimensions to specify in a tender line.
140 device records in commercial distribution are listed on the FDA Global Unique Device Identification Database (GUDID) under the GMDN category "Cannabinoid/cannabinoid metabolite IVD, kit, rapid ICT, clinical", from 35 companies. The largest labeler is Safecare Biotech (Hangzhou) Co., Ltd. with 16% of records.
LDJ (Enzyme Immunoassay, Cannabinoids), NFW (Test, Cannabinoid, Over The Counter), DIO (Enzyme Immunoassay, Cocaine And Cocaine Metabolites), DKZ (Enzyme Immunoassay, Amphetamine)
No. GUDID is the US register. For the UAE (MOHAP/DoH) and Saudi (SFDA/MDMA) a separate registration and a local authorised representative are required; Consulting Wallah can check the status and connect you with registered suppliers.
Add cannabinoid/cannabinoid metabolite ivd, kit, rapid ict, clinical to the RFQ basket or use the form below with quantity, specification and delivery location; the Network returns comparable quotes from verified suppliers in 2–5 working days.
Hospitals, pharmacies and distributors anywhere: tell us what you need and the Consulting Wallah Network returns comparable quotes from verified suppliers. No fee for buyers.
Source: FDA AccessGUDID (AccessGUDID full release 2 Nov 2026); counts are device records in commercial distribution grouped by GMDN preferred term; companies are labelers of record. Information only — US listing is not a registration in the UAE or GCC; verify with the regulator. © Consulting Wallah — CC BY‑NC‑ND.